Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;25(11):2399-418.
doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12.

Predictors of autosomal dominant polycystic kidney disease progression

Affiliations

Predictors of autosomal dominant polycystic kidney disease progression

Robert W Schrier et al. J Am Soc Nephrol. 2014 Nov.

Abstract

Autosomal dominant polycystic kidney disease is a genetic disorder associated with substantial variability in its natural course within and between affected families. Understanding predictors for rapid progression of this disease has become increasingly important with the emergence of potential new treatments. This systematic review of the literature since 1988 evaluates factors that may predict and/or effect autosomal dominant polycystic kidney disease progression. Predicting factors associated with early adverse structural and/or functional outcomes are considered. These factors include PKD1 mutation (particularly truncating mutation), men, early onset of hypertension, early and frequent gross hematuria, and among women, three or more pregnancies. Increases in total kidney volume and decreases in GFR and renal blood flow greater than expected for a given age also signify rapid disease progression. Concerning laboratory markers include overt proteinuria, macroalbuminuria, and perhaps, elevated serum copeptin levels in affected adults. These factors and others may help to identify patients with autosomal dominant polycystic kidney disease who are most likely to benefit from early intervention with novel treatments.

Keywords: PKD1/PKD2; autosomal dominant polycystic kidney disease; disease progression; hypertension; renal blood flow; total kidney volume.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Diagram depicting the spectrum of predictors for rapid renal disease progression in ADPKD. Shaded ovals represent the most established predictors.

References

    1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 - PubMed
    1. Takiar V, Caplan MJ: Polycystic kidney disease: Pathogenesis and potential therapies. Biochim Biophys Acta 1812: 1337–1343, 2011 - PMC - PubMed
    1. Fick-Brosnahan GM, Ecder T, Schrier RW: Polycystic kidney disease. In: Diseases of the Kidney, 7th Ed., edited by Schrier R, Philadelphia, Lippincott Williams & Wilkins, 2001, pp 547–588
    1. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Jr., Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, CRISP Investigators : Volume progression in polycystic kidney disease. N Engl J Med 354: 2122–2130, 2006 - PubMed
    1. Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo M-P, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y: Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24: 1006–1013, 2013 - PMC - PubMed

Publication types

MeSH terms

Substances